FTC still waiting for a pay-for-delay ruling
Tuesday, 8 March 2011
Rosalind Donald
The US Supreme Court has let an appeals court ruling stand allowing pharmaceutical companies to strike so-called ‘pay-for-delay’ deals with generic drug makers without violating antitrust law.
PREMIUM Subscription required to view this article
This content can only be accessed by PREMIUM GCR subscribers.
A premium subscription includes 10 issues of the journal, 2 signature surveys - The GCR100 and Rating Enforcement, 10 GCR special reports and full access to current and archived print & online content.
If you are a GCR subscriber, please login to access this content:
Comments
You must Subscribe or Log In to make comments.
Comment Terms & Conditions
Back to top